Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

about

Cancer-type OATP1B3 mRNA has the potential to become a detection and prognostic biomarker for human colorectal cancer.

P2860

Q50596135-442B6D81-95EE-426A-85AA-7682574A4F96

P2860

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

Item

http://www.wikidata.org/entity/Q28277670

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@ast

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@en

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@nl

type

Item

label

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@ast

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@en

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@nl

prefLabel

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@ast

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@en

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@nl

P1476

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

@en

P2093

Guodong Li

http://www.w3.org/2001/XMLSchema#string

Jiufeng Wei

http://www.w3.org/2001/XMLSchema#string

Kai Zeng

http://www.w3.org/2001/XMLSchema#string

Ming Liu

http://www.w3.org/2001/XMLSchema#string

Shuwei Dang

http://www.w3.org/2001/XMLSchema#string

Yuhui Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice

A genetic model for colorectal tumorigenesis

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer

Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain

A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the Infinium HumanMethylation450 BeadChip(®) for methylome profiling.

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.

Genome-scale analysis of aberrant DNA methylation in colorectal cancer.

Early detection of colon cancer-the kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients?

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study

P304

2192853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4543306

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/2192853

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27493446

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

clinical chemistry

P932

4963574

http://www.w3.org/2001/XMLSchema#string

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

about

P2860

P2860

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P478

P50

P577

P698

P921

P932